Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
Hamilton Trinh, Vicki Irish, Mireya Diaz, Humphrey Atiemo
Int Neurourol J. 2019;23(3):226-233. Published online 2019 Sep 30 DOI: https://doi.org/10.5213/inj.1938030.015
Citations to this article as recorded by 
OnabotulinumtoxinA discontinuation in patients with prior nerve stimulation
Katherine Woodburn, Elizabeth Hoang, Karen Quan, Jon Pennycuff, Lee A. Richter
Neurourology and Urodynamics.2023; 42(2): 436. CrossRef
Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients
Mathias Reekmans, Janine M. W. Janssen, Desiree M. J. Vrijens, Martijn A. C. Smits, Gommert A. van Koeveringe, Philip E. V. A. Van Kerrebroeck
Neurourology and Urodynamics.2021; 40(5): 1120. CrossRef
Botulinum toxin in low urinary tract disorders ‑ over 30 years of practice (Review)
Arsenie Spinu, Ovidiu Bratu, Camelia Diaconu, Ana Stanescu, Simona Bungau, Ovidiu Fratila, Roxana Bohiltea, Dan Mischianu
Experimental and Therapeutic Medicine.2020;[Epub] CrossRef
Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012–2016
Jong Won Kim, Hyun Kyu Ahn, Jongcheol Ko, Dongu Lee, Jee Soo Ha, Jae Hwan Kim, So Jeong Park, Kang Su Cho
International Neurourology Journal.2020; 24(3): 278. CrossRef
Catheter-Related Bladder Discomfort: How Can We Manage It?
Eun Bi Jang, Seong Hwi Hong, Kyu Shik Kim, Sung Yul Park, Yong Tae Kim, Young Eun Yoon, Hong Sang Moon
International Neurourology Journal.2020; 24(4): 324. CrossRef